Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK

Rory J. McCrimmon, Edel Falla, Jo Zhou Sha, Abdul Jabbar Omar Alsaleh, Elisheva Lew (Lead / Corresponding author), Richard Hudson, Mike Baxter, Karen Palmer

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
25 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK'. Together they form a unique fingerprint.

Medicine & Life Sciences